SOX2 and neoplasm: Interestingly, immunostaining found that, while circFat1 reduced SOX2+ tumor cells, SOX2+ tumor cells were enriched after anti‐PD1 treatment, indicating that SOX2+ tumor cells were intrinsically resistant to PD1 blockade.